- Home
- ALT vs MATV Comparison
ALT vs MATV Comparison
Compare ALT & MATV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | MATV |
|---|---|---|
| Founded | 1997 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.0M | 644.7M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALT | MATV |
|---|---|---|
| Price | $5.32 | $12.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $16.33 | $10.00 |
| AVG Volume (30 Days) | ★ 3.5M | 301.9K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 3.17% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $20,000.00 | ★ $1,982,500,000.00 |
| Revenue This Year | N/A | $2.62 |
| Revenue Next Year | N/A | $2.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.39 |
| 52 Week Low | $2.90 | $4.34 |
| 52 Week High | $9.59 | $13.57 |
Technical Indicators
Market Signals| Indicator | ALT | MATV |
|---|---|---|
| Relative Strength Index (RSI) | 61.41 | 57.35 |
| Support Level | $5.03 | $11.78 |
| Resistance Level | $5.83 | $12.26 |
| Average True Range (ATR) | 0.38 | 0.42 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 47.00 | 65.25 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About MATV Mativ Holdings Inc.
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments namely Filtration & advanced Materials focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging and healthcare solutions.